EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Survodutide Once Weekly for the Treatment of Adults with Obesity

Carel W le Roux, Sean Wharton, Elena Startseva, Isabel M Kloer, Samina Ajaz Hussain, Anna Unseld, Biykem Bozkurt, Jamy D Ard, Harold E Bays, Pawel Bogdański, Elif I Ekinci, Ania M Jastreboff iD und 13 weitere

New England Journal of Medicine · 20.08.2026 · 395 (8) · 776-787

DOI: 10.1056/nejmoa2600751 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 20.08.2026. Verfasst von Carel W le Roux und 24 weiteren Autor:innen. Beteiligte Einrichtung: University College Dublin School of Medicine, Dublin. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptides, Obesity. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like PeptidesObesityAdultFemaleHumansMaleMiddle AgedYoung AdultBody Mass IndexCounselingDouble-Blind MethodDrug Administration ScheduleDrugs, InvestigationalInjections, SubcutaneousReceptors, GlucagonWeight LossTreatment Outcome

Substanzen

Anti-Obesity AgentsDrugs, InvestigationalGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like PeptidesReceptors, Glucagonsurvodutide

Autor:innen und Institutionen

  • University College Dublin School of Medicine, Dublin.
  • Ulster University, Coleraine, United Kingdom.
  • McMaster University, Hamilton, ON, Canada.
  • University of Toronto, Toronto.
  • Boehringer Ingelheim International, Ingelheim am Rhein, Germany.
  • Boehringer Ingelheim Pharma, Biberach, Germany.

ORCID-Profile: Ania M Jastreboff, Linong Ji, Naveed Sattar, André P van Beek, Roman Vangoitsenhoven

Förderung

  • Boehringer Ingelheim

Zitieren

APA

le Roux, C. W., Wharton, S., Startseva, E., Kloer, I. M., Hussain, S. A., Unseld, A., Bozkurt, B., Ard, J. D., Bays, H. E., Bogdański, P., Ekinci, E. I., Jastreboff, A. M., Ji, L., Ogawa, W., Pedersen, S. D., Pietiläinen, K. H., Sattar, N., Seufert, J., Stenlöf, K., …, & SYNCHRONIZE-1 Investigators (2026). Survodutide Once Weekly for the Treatment of Adults with Obesity. New England Journal of Medicine, 395(8), 776-787. https://doi.org/10.1056/nejmoa2600751

Vancouver

le Roux CW, Wharton S, Startseva E, Kloer IM, Hussain SA, Unseld A, et al. Survodutide Once Weekly for the Treatment of Adults with Obesity. New England Journal of Medicine. 2026;395(8):776-787. doi:10.1056/nejmoa2600751

BibTeX
@article{leRoux2026,
  author = {le Roux, Carel W and Wharton, Sean and Startseva, Elena and Kloer, Isabel M and Hussain, Samina Ajaz and Unseld, Anna and Bozkurt, Biykem and Ard, Jamy D and Bays, Harold E and Bogdański, Pawel and Ekinci, Elif I and Jastreboff, Ania M and Ji, Linong and Ogawa, Wataru and Pedersen, Sue D and Pietiläinen, Kirsi H and Sattar, Naveed and Seufert, Jochen and Stenlöf, Kaj and van Beek, André P and Vangoitsenhoven, Roman and Brueckmann, Martina and Younes, Ramy and Kaplan, Lee M and SYNCHRONIZE-1 Investigators, SYNCHRONIZE-1 Investigators},
  title = {Survodutide Once Weekly for the Treatment of Adults with Obesity},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {8},
  pages = {776--787},
  doi = {10.1056/nejmoa2600751}
}
Kostenlos starten →